does medicare cover glp-1 weight loss medication? Medicare Spending on Ozempic and
Description
Discover trends in diabetes care, weight-loss demand, pricing, and generics.
Considerations for employers who are thinking about covering GLP-1 drugs for weight loss.
Reddys Laboratories has launched Obeda, an injectable semaglutide therapy for diabetes and weight management in India.
Newly released clinical trial data on the GLP-1 agonist drug Wegovy found that weight loss was sustained for up to four years after participants started taking the once-weekly injected medication
Read the FDAs full warning here: #GLP1 #ClinicalTrials #PatientSafety #AccessEquity #ObesityResearch #DecentralizedTrials
